Key result
Inducing very low myocyte apoptosis causes lethal dilated cardiomyopathy in mice.
Why the study?
The pathogenesis of heart failure is poorly understood, and the causal role of low levels of cardiac myocyte apoptosis in heart failure remains unclear.
Does myocyte apoptosis cause heart failure, and does its inhibition prevent cardiac dilation and contractile dysfunction in a transgenic mouse model?
Does myocyte apoptosis cause heart failure, and does its inhibition prevent cardiac dilation and contractile dysfunction in a transgenic mouse model?
This study provides direct evidence that very low levels of myocyte apoptosis can cause heart failure, suggesting apoptosis inhibition as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Apoptosis inhibition merits study as a heart failure target; leaves open translation from transgenic mice to patients.
Heart failure is a common, lethal condition whose pathogenesis is poorly understood. Recent studies have identified low levels of myocyte apoptosis (80–250 myocytes per 10(5) nuclei) in failing human hearts. It remains unclear, however, whether this cell death is a coincidental finding, a protective process, or a causal component in pathogenesis. Using transgenic mice that express a conditionally active caspase exclusively in the myocardium, we demonstrate that very low levels of myocyte apoptosis (23 myocytes per 10(5) nuclei, compared with 1.5 myocytes per 10(5) nuclei in controls) are sufficient to cause a lethal, dilated cardiomyopathy. Interestingly, these levels are four- to tenfold lower than those observed in failing human hearts. Conversely, inhibition of cardiac myocyte death in this murine model largely prevents the development of cardiac dilation and contractile dysfunction, the hallmarks of heart failure. To our knowledge, these data provide the first direct evidence that myocyte apoptosis may be a causal mechanism of heart failure, and they suggest that inhibition of this cell death process may constitute the basis for novel therapies.
No takes yet. Share an insight, caveat, or question.
Wencker et al. (2003) studied Heart failure. Conditionally active caspase expression (induction of myocyte apoptosis) vs. Controls was evaluated on Development of lethal, dilated cardiomyopathy. Induction of very low levels of myocyte apoptosis (23 per 10^5 nuclei) in transgenic mice was sufficient to cause lethal, dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: